Compare VRAR & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRAR | ELUT |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.5M | 23.3M |
| IPO Year | 2021 | 2020 |
| Metric | VRAR | ELUT |
|---|---|---|
| Price | $0.78 | $1.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $2.62 | ★ $7.00 |
| AVG Volume (30 Days) | 108.2K | ★ 266.8K |
| Earning Date | 02-17-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $9,488,209.00 | ★ $21,746,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $72.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 16.60 | ★ 24.08 |
| 52 Week Low | $0.74 | $0.50 |
| 52 Week High | $1.87 | $3.46 |
| Indicator | VRAR | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 36.10 | 63.04 |
| Support Level | $0.74 | $0.85 |
| Resistance Level | $0.96 | $1.04 |
| Average True Range (ATR) | 0.10 | 0.11 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 8.51 | 66.61 |
The Glimpse Group Inc is a diversified immersive technology platform company, focused on providing enterprise solutions in virtual reality (VR), augmented reality (AR), and spatial computing. The company operates multiple subsidiaries that develop VR and AR software and services across various industries, including corporate training, education, healthcare, government, defense, marketing, retail, and financial services. It also offers AI-driven spatial computing platforms that support simulations, social VR, behavioral health, and corporate events. The Company reports its revenues in three categories: Software Services, Software License and Software-as-a-Service (SaaS), and Royalty Income, with the majority being from the Software Services category.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.